@misc{indiciaed46c5fb49b01,
  title = {Combinations of RAS pathway inhibitors with targeted agents are active in spheroids of patient-derived cells with oncogenic KRAS variants from multiple cancer types},
  author = {Davoudi, Z. and Dexheimer, T. S. and Coussens, N. P. and Silvers, T. and Morris, J. and Takebe, N. and Doroshow, J. H. and Teicher, B. A.},
  year = {2024},
  doi = {10.1101/2024.11.17.623998},
  url = {https://www.biorxiv.org/content/10.1101/2024.11.17.623998v1},
  note = {Source identifier: 10.1101/2024.11.17.623998}
}